Centiva Capital’s USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 HUGS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-107,170
Closed -$178K 1944
2021
Q4
$178K Buy
107,170
+18,966
+22% +$28.8K ﹤0.01% 1015
2021
Q3
$76K Buy
88,204
+47,900
+119% +$46.4K ﹤0.01% 1096
2021
Q2
$42K Buy
+40,304
New +$38.9K ﹤0.01% 1289

Other funds holding HUGS.WS

Centiva Capital's HUGS.WS Position: Q1 2022 in Review

Centiva Capital sold out of USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (HUGS.WS) in Q1 2022, closing a stake of 107,170 shares — an estimated $178K sold.

Centiva Capital first reported a position in HUGS.WS in Q2 2021 and held it in 3 quarters. The position peaked at $178K in Q4 2021. 38 funds tracked by Wall St. Rank hold HUGS.WS as of Q1 2022.

  • Centiva Capital reported no remaining USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Centiva Capital sold 107,170 USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q1 2022, an estimated $178K.
  • Centiva Capital first reported a position in USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q2 2021 and held it in 3 quarters.
  • Centiva Capital's USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $178K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q1 2022.

Based on Centiva Capital's 13F filing for Q1 2022, filed 16 May 2022.